about
Pediatric medulloblastoma - update on molecular classification driving targeted therapiesMolecular subgroups of medulloblastoma: the current consensusCross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenanceDNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesClinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature.A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors.DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis.Activation of Wnt/β-catenin signalling affects differentiation of cells arising from the cerebellar ventricular zoneA microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.Overcoming multiple drug resistance mechanisms in medulloblastoma.Molecular subgroups of medulloblastoma.Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells featuresRapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesGlobal gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma.The molecular classification of medulloblastoma: driving the next generation clinical trials.An interferon response gene expression signature is activated in a subset of medulloblastomasMolecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiationSubgroup-specific prognostic implications of TP53 mutation in medulloblastoma.REST is a novel prognostic factor and therapeutic target for medulloblastomaCytogenetic prognostication within medulloblastoma subgroups.Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.Targeted treatment for sonic hedgehog-dependent medulloblastoma.Medulloblastoma: recurrence and metastasis.Endoscopic biopsy of brain tumors: Does the technique matter?Medulloblastoma development: tumor biology informs treatment decisionsMolecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis.Medulloblastoma: selecting children for reduced treatment.
P2860
Q21129295-9DBCF049-BCF5-443B-AC92-38FACE4B121CQ24615271-6799A1E2-8C44-4EB5-B61E-7B1E43536CABQ27310060-E95DB1A1-4C99-498C-872E-74393B434000Q28282708-DF210C0D-64DA-45A7-8E08-D56E364B9183Q31043687-4460B472-1611-45D8-A4E3-A41AE69BFEE1Q33764533-43CEE400-F1E6-4DAD-A376-A53B4AD52215Q34330397-D2301B2E-73F1-4F81-B9C7-8BB23D56E23DQ34374349-8B8EC7A2-DF4C-48CB-A61A-E0713C9A023CQ34457533-18E3C16E-306E-41C9-B6B2-5ADF15B23AC2Q34500602-C0F5FFAE-D9C1-4AB5-82C0-0BB8C20E6754Q35101347-675A6C8D-5B78-4C87-8F0A-264E5856E419Q35150189-90847A2F-01C6-4E28-8159-749A39BB564CQ35837393-A9A1093F-A006-4ED8-9C11-23023CFAD4A0Q35914511-4DD046B9-D26F-431D-8F4F-840D92F9097BQ35946293-EED8240D-563F-4B3F-9CC1-3BD639EB3018Q36199866-B1B7BF9E-A3F1-479A-AD35-E3697BC7A8A3Q36367397-02A2BD29-821B-4989-B3DF-6C377F8A18B4Q36893363-5E0CA698-6E16-4A12-AC1C-1D6BE53F8C01Q36929844-EBB07571-09F1-464F-99F6-8E07CB1E4A1CQ37148990-21E33EAE-0B80-4935-870F-879EDE51DBA1Q37627692-47984F2D-334B-4DC6-8710-1CBB60860C08Q38121136-5B959C16-D6C5-4E3E-8A22-8DFE236596CAQ38222028-619798D9-23A3-489E-9327-838D9D014093Q38233118-7F591F07-C434-4669-A3BA-87B2D73DA062Q38288352-2B9D7F37-05AE-4A95-B8C0-F9745A5E8138Q38376606-64E4E376-0E6A-4A78-B87D-393FA5E858FFQ39181104-A9CE561F-8C7A-4C00-9D56-F7F336E57D05Q39679776-20140945-287E-46AF-99C1-A6DBD4670F70Q40682183-3CE0125D-4578-48AF-9F10-AB703E2F947DQ47715340-9E3031F5-CE98-461A-AC1A-B9B9F1DEB5CAQ47823690-D1EC91B8-E4B4-4CF2-A7DA-C50851AABDD4Q48182545-03336285-E13D-4096-A5EF-7D880D559292Q50604253-4BB76C5A-C9FA-4B21-99A0-869E9A4ABB45
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rapid diagnosis of medulloblastoma molecular subgroups.
@ast
Rapid diagnosis of medulloblastoma molecular subgroups.
@en
Rapid diagnosis of medulloblastoma molecular subgroups.
@nl
type
label
Rapid diagnosis of medulloblastoma molecular subgroups.
@ast
Rapid diagnosis of medulloblastoma molecular subgroups.
@en
Rapid diagnosis of medulloblastoma molecular subgroups.
@nl
prefLabel
Rapid diagnosis of medulloblastoma molecular subgroups.
@ast
Rapid diagnosis of medulloblastoma molecular subgroups.
@en
Rapid diagnosis of medulloblastoma molecular subgroups.
@nl
P2093
P2860
P1476
Rapid diagnosis of medulloblastoma molecular subgroups.
@en
P2093
David W Ellison
Debbie Straughton
Ed C Schwalbe
Hisham Megahed
Janet C Lindsey
Meryl E Lusher
Michael Cole
Michael D Taylor
Richard J Gilbertson
Sarra L Ryan
P2860
P304
P356
10.1158/1078-0432.CCR-10-2210
P407
P577
2011-02-16T00:00:00Z